{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:16:17Z","timestamp":1764688577007},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ygyno.2006.09.013","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T16:06:01Z","timestamp":1161187561000},"page":"524-528","source":"Crossref","is-referenced-by-count":35,"title":["PDGFR-\u03b1 as a potential therapeutic target in uterine sarcomas"],"prefix":"10.1016","volume":"104","author":[{"given":"S.F.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Y.","family":"Hutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Montag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.D.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2006.09.013_bib2","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(20000615)88:12<2782::AID-CNCR17>3.0.CO;2-K","article-title":"Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus","volume":"88","author":"Yamada","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2006.09.013_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2006.09.013_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001622-200107000-00007","article-title":"Signal transduction pathways in sarcoma as targets for therapeutic intervention","volume":"13","author":"Tuveson","year":"2001","journal-title":"Curr. Opin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2006.09.013_bib5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.20.6.1692","article-title":"Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies","volume":"20","author":"Heinrich","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2006.09.013_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ajhp\/60.12.1233","article-title":"Targeted drugs in oncology: new names, new mechanisms, new paradigm","volume":"60","author":"Rotea","year":"2003","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ygyno.2006.09.013_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.ygyno.2006.09.013_bib8","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.013_bib9","first-page":"6344","article-title":"In situ distribution of the \u03b2 subunit of platelet-derived growth factor receptor in nonneoplastic tissue and in soft tissue tumors","volume":"50","author":"Franklin","year":"1990","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2006.09.013_bib10","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1210\/jc.87.5.2310","article-title":"Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B and PDGF Receptor-\u03b1 and -\u03b2 during human testicular development and disease","volume":"87","author":"Basciani","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ygyno.2006.09.013_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies","volume":"26","author":"Oliva","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2006.09.013_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","article-title":"Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa","volume":"28","author":"Silva","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"22","key":"10.1016\/j.ygyno.2006.09.013_bib13","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1200\/JCO.2004.10.125","article-title":"Prevalence of KIT expression in human tumors","volume":"22","author":"Went","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2006.09.013_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0090-8258(03)00332-9","article-title":"A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets","volume":"90","author":"Ramondetta","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9440(10)65250-9","article-title":"Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas","volume":"154","author":"Lasota","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.pgp.0000183047.45459.36","article-title":"Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region","volume":"25","author":"Nakayama","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2006.09.013_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0090-8258(03)00274-9","article-title":"The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus","volume":"90","author":"Wang","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2003.06.001","article-title":"Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus","volume":"91","author":"Winter","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0090-8258(03)00442-6","article-title":"Uterine sarcomas express KIT protein but lack mutations in exon 11 or 17 of c-KIT","volume":"91","author":"Rushing","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2006.09.013_bib20","first-page":"1","article-title":"Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series","volume":"49","author":"Leath","year":"2004","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2006.09.013_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2004.09.050","article-title":"COX-2, c-KIT and HER-2\/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?","volume":"96","author":"Raspollini","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.013_bib22","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1158\/1078-0432.CCR-03-0363","article-title":"c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment","volume":"10","author":"Raspollini","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2006.09.013_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jmg.2004.024034","article-title":"A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas","volume":"42","author":"De Bustos","year":"2005","journal-title":"J. Med. Genet."},{"issue":"16","key":"10.1016\/j.ygyno.2006.09.013_bib24","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1073\/pnas.151173398","article-title":"A role of PDGFRalpha in basal cell carcinoma proliferation","volume":"98","author":"Jingwu","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygyno.2006.09.013_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2005.02.093","article-title":"KIT and platelet-derived growth receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors","volume":"23","author":"Sihto","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.013_bib26","first-page":"114","article-title":"Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity","volume":"60","author":"Fujii","year":"2000","journal-title":"Cancer Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580600713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580600713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T18:21:43Z","timestamp":1555870903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082580600713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S009082580600713X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.09.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}